Investors sold shares of Humana Inc. (NYSE:HUM) on strength during trading hours on Friday. $78.68 million flowed into the stock on the tick-up and $128.40 million flowed out of the stock on the tick-down, for a money net flow of $49.72 million out of the stock. Of all stocks tracked, Humana had the 30th highest net out-flow for the day. Humana traded up $0.48 for the day and closed at $233.08
Several research firms have weighed in on HUM. UBS AG restated a “neutral” rating and issued a $250.00 price objective (up previously from $237.00) on shares of Humana in a research report on Wednesday. Cantor Fitzgerald restated a “neutral” rating and issued a $223.00 price objective (up previously from $200.00) on shares of Humana in a research report on Thursday, August 3rd. Jefferies Group LLC reiterated a “hold” rating and set a $257.00 price target on shares of Humana in a research report on Friday, August 4th. Deutsche Bank AG lifted their price target on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research report on Monday. Finally, Piper Jaffray Companies lifted their price target on shares of Humana to $280.00 and gave the stock an “overweight” rating in a research report on Thursday, August 3rd. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $243.65.
The stock has a market capitalization of $36.85 billion, a price-to-earnings ratio of 20.97 and a beta of 0.91. The firm has a 50 day moving average of $237.33 and a 200-day moving average of $221.21.
Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The company had revenue of $13.53 billion during the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the previous year, the firm earned $2.30 earnings per share. Equities analysts expect that Humana Inc. will post $11.45 EPS for the current fiscal year.
In other Humana news, SVP Brian P. Leclaire sold 4,971 shares of the business’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the completion of the sale, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Heidi S. Margulis sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, May 26th. The shares were sold at an average price of $231.96, for a total value of $347,940.00. Following the completion of the sale, the vice president now owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The disclosure for this sale can be found here. Insiders own 0.80% of the company’s stock.
Several institutional investors have recently bought and sold shares of HUM. Guardian Life Insurance Co. of America boosted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the last quarter. Independent Portfolio Consultants Inc. boosted its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the last quarter. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Humana during the first quarter valued at $128,000. Fiduciary Trust Co. purchased a new stake in shares of Humana during the second quarter valued at $135,000. Finally, Westbourne Investment Advisors Inc. purchased a new stake in shares of Humana during the second quarter valued at $205,000. 99.66% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Traders Sell Shares of Humana Inc. (NYSE:HUM) on Strength (NYSE:HUM)” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://stocknewstimes.com/2017/08/09/traders-sell-shares-of-humana-inc-nysehum-on-strength-nysehum-updated.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
